The effect of taping on performance in athletes with patellofemoral pain syndrome

The comparison of two taping methods on pain, EMG activity and dynamic balance in athletes with patellofemoral pain syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014071515932N3

Enrollment

Registered

2014-08-16

Start date

2014-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral pain syndrome. Chondromalacia

Interventions

Intervention 1: Kinesiologic tape will be attached with 15%-25% tension to VL inhibitory group from insertion to origin so it will be applied from tibial tuberosity following VL path, up to 1/3 of t

Rehabilitation

Kinesiologic tape will be attached with 15%-25% tension to VL inhibitory group from insertion to origin so it will be applied from tibial tuberosity following VL path, up to 1/3 of the proximal tigh

For VMO facillatory group tape with 25%-50% tension will be attached from origin to insertion so it will be applied from 1/3 of the proximal tigh following VMO path down to tibial tuberosity

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion critria: unilateral anterior or retropatellar knee pain while engaged in at least 2 of the following activities: prolonged sitting, climbing stairs, squatting, running, kneeling and jumping; existance of symptoms for at least 2 month; an average pain level of 3cm on a 10-cm visual analog scale; an insidious onset of symptoms unrelated to a traumatic incident and at least grade 11 in Functional Index Questionnaire. ?Exclusion critria: recent history of hip; knee or ankle surgery; a history of patellar dislocation or subluxation; or clinical evidence of meniscal lesion; ligamentous instability; patellar tendon pathology; chondral damage; osteoarthritis; or spinal referred pain; systemic diseases such as diabetes and rheumatism and bilateral PFP.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The onse and amplitude of electromyographic activity. Timepoint: Before the intervention and immediately after intervention. Method of measurement: Telemetry EMG (Mega electronics Ltd.Finland).;Pain. Timepoint: Before the intervention and immediately after intervention. Method of measurement: Visual analog scale.;Reach distance in dynamic balance. Timepoint: Before the intervention and immediately after intervention. Method of measurement: Tape.	—

Measure

Time frame

The onse and amplitude of electromyographic activity. Timepoint: Before the intervention and immediately after intervention. Method of measurement: Telemetry EMG (Mega electronics Ltd.Finland).;Pain. Timepoint: Before the intervention and immediately after intervention. Method of measurement: Visual analog scale.;Reach distance in dynamic balance. Timepoint: Before the intervention and immediately after intervention. Method of measurement: Tape.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahideh Foroozantabar

Shiraz School of Rehabilitation, Shiraz University of Medical Sciences

Foroozantabar.v@gmail.com+98 71 1626 2240

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026